Prognosis of Rectal Neuroendocrine Tumors After Endoscopic Resection: a Single-center Retrospective Study

Overview

Journal J Gastrointest Oncol

Date 2022 Jan 24

PMID 35070405

Authors

Yue Zheng

Kehang Guo

Ruijie Zeng

Zhendao Chen

Wanwei Liu

Xiaoguang Zhang

Weimin Liang

Jianhua Liu

Hao Chen

Weihong Sha

Affiliations

Soon will be listed here.

Abstract

Background: The efficacy of endoscopic resection in patients with rectal neuroendocrine tumors (NETs) which are less than 20 mm in diameter remains unclear. This study aimed to investigate the efficacy and outcomes of different types of endoscopic resection in patients with NETs.

Methods: We performed a retrospective analysis and follow-up on 98 patients who underwent endoscopic resection for rectal NETs between August 2010 and October 2019 at Guangdong Provincial People's Hospital, China. The lesions were preoperatively classified according to their endoscopic morphology and measured by endoscopic ultrasound. Patients were divided into modified endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) groups depending on the endoscopic treatment they received. The resection rate, histopathological complete resection rate, and the complication rate of the 2 groups were evaluated after the operation. The risk factors for incomplete resection were also analyzed.

Results: The average diameter of the 98 NETs was 6.29±2.90 mm (range, 2-15 mm). The resection rate of the modified EMR and ESD treatment groups was 97.2% (35/36) and 100% (62/62), respectively. The histopathological complete resection rate was 86.1% (31/36) and 87.1% (54/62), respectively. No tumor recurrence or tumor-related death occurred. There were no statistically significant differences in the rate of histopathological complete resection, perforation, or delayed hemorrhage between the 2 groups (P>0.05). Multivariate analysis demonstrated that the depth of tumor invasion (P=0.007) and tumor diameter (P<0.001) were independent risk factors for histopathological complete resection.

Conclusions: Modified EMR and ESD are safe and effective endoscopic approaches for the resection of rectal NETs ≤15 mm in diameter. Endoscopic resection requires a comprehensive preoperative evaluation of risk factors including the depth of tumor invasion and tumor diameter.

Citing Articles

Comparison of endoscopic submucosal dissection and transanal endoscopic microsurgery for stage 1 rectal neuroendocrine tumors.

Weng J, Chi J, Lv Y, Chen R, Xu G, Xia X World J Gastrointest Endosc. 2025; 17(2):99906.

PMID: 39989850 PMC: 11843039. DOI: 10.4253/wjge.v17.i2.99906.

Endoscopic treatment for rectal neuroendocrine tumor: which method is better?.

Hong S, Baek D Clin Endosc. 2022; 55(4):496-506.

PMID: 35811403 PMC: 9329644. DOI: 10.5946/ce.2022.115.

References

de Mestier L, Lepage C, Baudin E, Coriat R, Courbon F, Couvelard A . Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR). Dig Liver Dis. 2020; 52(5):473-492. DOI: 10.1016/j.dld.2020.02.011. View

Eick J, Steinberg J, Schwertner C, Ring W, Scherubl H . [Rectal neuroendocrine tumors: endoscopic therapy]. Chirurg. 2016; 87(4):288-91. DOI: 10.1007/s00104-015-0141-6. View

Caplin M, Sundin A, Nillson O, Baum R, Klose K, Kelestimur F . ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. Neuroendocrinology. 2012; 95(2):88-97. DOI: 10.1159/000335594. View

Naunheim K, Zeitels J, Kaplan E, Sugimoto J, Shen K, Lee C . Rectal carcinoid tumors--treatment and prognosis. Surgery. 1983; 94(4):670-6. View

Wang X, Chai N, Linghu E, Qiu S, Li L, Zou J . The outcomes of modified endoscopic mucosal resection and endoscopic submucosal dissection for the treatment of rectal neuroendocrine tumors and the value of endoscopic morphology classification in endoscopic resection. BMC Gastroenterol. 2020; 20(1):200. PMC: 7318520. DOI: 10.1186/s12876-020-01340-w. View

Park S, Kim D, Kim H, Choi C, Kang D, Kim S . Is endoscopic ultrasonography essential for endoscopic resection of small rectal neuroendocrine tumors?. World J Gastroenterol. 2017; 23(11):2037-2043. PMC: 5360645. DOI: 10.3748/wjg.v23.i11.2037. View

Ko S, Baeg M, Ko S, Jung H . Clinical characteristics, risk factors and outcomes of asymptomatic rectal neuroendocrine tumors. Surg Endosc. 2017; 31(10):3864-3871. DOI: 10.1007/s00464-016-5413-9. View

Jeon J, Cheung D, Lee S, Kim H, Kim H, Cho H . Endoscopic resection yields reliable outcomes for small rectal neuroendocrine tumors. Dig Endosc. 2014; 26(4):556-63. DOI: 10.1111/den.12232. View

Nagtegaal I, Odze R, Klimstra D, Paradis V, Rugge M, Schirmacher P . The 2019 WHO classification of tumours of the digestive system. Histopathology. 2019; 76(2):182-188. PMC: 7003895. DOI: 10.1111/his.13975. View

10.

Tsai H, Wu C, Tsai C, Lin S, Chen L, Chang J . The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study. PLoS One. 2013; 8(4):e62487. PMC: 3632554. DOI: 10.1371/journal.pone.0062487. View

11.

Perren A, Couvelard A, Scoazec J, Costa F, Borbath I, Delle Fave G . ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology: Diagnosis and Prognostic Stratification. Neuroendocrinology. 2017; 105(3):196-200. DOI: 10.1159/000457956. View

12.

Pavel M, Oberg K, Falconi M, Krenning E, Sundin A, Perren A . Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020; 31(7):844-860. DOI: 10.1016/j.annonc.2020.03.304. View

13.

Jung E, Kang Y, Cho M, Kim J, Lee W, Lee H . Update on the proposal for creating a guideline for cancer registration of the gastrointestinal tumors (I-2). Korean J Pathol. 2012; 46(5):443-53. PMC: 3490113. DOI: 10.4132/KoreanJPathol.2012.46.5.443. View

14.

Kang H, Kwon M, Kim T, Han J, Ju Y . Lymphovascular invasion as a prognostic value in small rectal neuroendocrine tumor treated by local excision: A systematic review and meta-analysis. Pathol Res Pract. 2019; 215(11):152642. DOI: 10.1016/j.prp.2019.152642. View

15.

Bang B, Park J, Kim H, Shin Y, Kwon K, Kim J . Endoscopic Resection for Small Rectal Neuroendocrine Tumors: Comparison of Endoscopic Submucosal Resection with Band Ligation and Endoscopic Submucosal Dissection. Gastroenterol Res Pract. 2016; 2016:6198927. PMC: 4976186. DOI: 10.1155/2016/6198927. View

16.

Singh S, Moody L, Chan D, Metz D, Strosberg J, Asmis T . Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors. JAMA Oncol. 2018; 4(11):1597-1604. DOI: 10.1001/jamaoncol.2018.2428. View

17.

Shah M, Goldner W, Halfdanarson T, Bergsland E, Berlin J, Halperin D . NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018. J Natl Compr Canc Netw. 2018; 16(6):693-702. DOI: 10.6004/jnccn.2018.0056. View

18.

Zheng J, Zheng K, Zhao S, Wang Z, Xu H, Jiang C . Efficacy and safety of modified endoscopic mucosal resection for rectal neuroendocrine tumors: a meta-analysis. Z Gastroenterol. 2020; 58(2):137-145. DOI: 10.1055/a-1062-8897. View

19.

Pape U, Perren A, Niederle B, Gross D, Gress T, Costa F . ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. Neuroendocrinology. 2012; 95(2):135-56. DOI: 10.1159/000335629. View

20.

Taghavi S, Jayarajan S, Powers B, Davey A, Willis A . Examining rectal carcinoids in the era of screening colonoscopy: a surveillance, epidemiology, and end results analysis. Dis Colon Rectum. 2013; 56(8):952-9. DOI: 10.1097/DCR.0b013e318291f512. View